Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening
David A. Lieberman(Oregon Health & Science University), Rosita van den Puttelaar(Erasmus MC), Folasade P. May(University of California, Los Angeles), John M. Inadomi(University of Washington), Timothy R. Church(University of Minnesota), John M. Carethers(University of San Diego), Iris Lansdorp‐Vogelaar, Richard C. Wender(American Cancer Society), Uri Ladabaum(Stanford University), Anjelica Q. Davis, Aasma Shaukat(New York University), Pedro Nascimento de Lima(RAND Corporation), Chyke A. Doubeni(Mayo Clinic)
Cited by 17
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States
|Clinical Infectious Diseases|2020|1.5k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k
American Gastroenterological Association Technical Review on the Management of Barrett's Esophagus
|Gastroenterology|2011|1.1k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k